Highbridge Capital Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-241,475
Closed -$6.28M 504
2018
Q2
$6.28M Sell
241,475
-20,309
-8% -$524K 0.13% 217
2018
Q1
$7.59M Sell
261,784
-108,013
-29% -$3.14M 0.12% 208
2017
Q4
$9.71M Buy
+369,797
New +$10.6M 0.17% 165
2016
Q3
Sell
-217,405
Closed -$2.58M 1313
2016
Q2
$2.58M Buy
217,405
+175,080
+414% +$2.18M 0.04% 373
2016
Q1
$546K Buy
+42,325
New +$541K 0.01% 949
2015
Q4
Sell
-56,568
Closed -$477K 1494
2015
Q3
$477K Buy
+56,568
New +$437K 0.01% 1046
2015
Q2
Sell
-147,448
Closed -$1.02M 1393
2015
Q1
$1.02M Buy
+147,448
New +$1.35M 0.01% 747
2014
Q4
Sell
-116,453
Closed -$1.53M 1165
2014
Q3
$1.53M Buy
+116,453
New +$1.53M 0.02% 543

Other funds holding BAK

Highbridge Capital Management's BAK Position: Q3 2018 in Review

Highbridge Capital Management sold out of Braskem (BAK) in Q3 2018, closing a stake of 241,475 shares — an estimated $6.28M sold.

Highbridge Capital Management first reported a position in BAK in Q3 2014 and held it in 8 quarters. The position peaked at $9.71M in Q4 2017. 93 funds tracked by Wall St. Rank hold BAK as of Q3 2018.

  • Highbridge Capital Management reported no remaining Braskem position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 241,475 Braskem shares in Q3 2018, an estimated $6.28M.
  • Highbridge Capital Management first reported a position in Braskem in Q3 2014 and held it in 8 quarters.
  • Highbridge Capital Management's Braskem position peaked at $9.71M in Q4 2017.
  • 93 funds tracked by Wall St. Rank held Braskem as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.